文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性呼吸窘迫综合征中右心室特异性治疗:范围综述

Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review.
PubMed 文献 · Crit Care · 2023-03-12
一句话结论在ARDS合并右心室功能障碍中,仅5.9%的研究为随机对照试验,作者认为亟需针对右心室功能障碍的前瞻性试验。

该范围综述检索MEDLINE、Embase、CINAHL、Web of Science和Cochrane Central Register of Controlled Trials,从1430项筛选中纳入51项研究、共1526例患者。干预按频率依次为吸入药物(33.3%)、呼吸机设置(29.4%)、体外生命支持(13.7%)、静脉或口服药物(13.7%)和俯卧位(9.8%);研究类型以非随机实验研究(53%)最常见,其次为病例报告(16%),仅5.9%为随机对照试验;27%的研究以改善右心室功能为目标。作者认为,鉴于ARDS中右心室功能障碍的普遍性及其与死亡率的关联,该领域研究匮乏令人担忧,并强调需要针对ARDS右心室功能障碍治疗的前瞻性试验。

要点

  • 范围综述纳入51项研究、1526例患者,仅5.9%为随机对照试验,53%为非随机实验研究、16%为病例报告。
  • 干预按频率依次为吸入药物33.3%、呼吸机设置29.4%、体外生命支持13.7%、静脉或口服药物13.7%、俯卧位9.8%。
  • 仅27%的研究以改善右心室功能为目标,其余研究仅报告治疗对右心室功能的影响。
  • 作者认为ARDS中右心室功能障碍常见且与死亡率相关,但相关研究匮乏令人担忧。
  • 作者强调需要针对ARDS右心室功能障碍治疗的前瞻性试验。

适用人群与场景

  • 急性呼吸窘迫综合征(ARDS)患者,研究需报告治疗对右心室功能的影响,无论是否以改善右心室功能为目的。

研究设计与关键结果

  • 研究类型为范围综述,检索MEDLINE、Embase、CINAHL、Web of Science和Cochrane Central Register of Controlled Trials,筛查1430项研究后纳入51项研究、共1526例患者。
  • 干预按频率依次为:呼吸机设置29.4%、吸入药物33.3%、体外生命支持13.7%、静脉或口服药物13.7%、俯卧位9.8%。
  • 研究类型以非随机实验研究(53%)最常见,其次为病例报告(16%),仅5.9%为随机对照试验。
  • 27%的研究以改善右心室功能为目标。

证据类型、等级与局限

  • 证据类型:范围综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,鉴于ARDS中右心室功能障碍的普遍性及其与死亡率的关联,该领域研究匮乏令人担忧。
  • 作者强调需要针对ARDS右心室功能障碍治疗的前瞻性试验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To summarize knowledge and identify gaps in evidence regarding treatment of right ventricular dysfunction (RVD) in acute respiratory distress syndrome (ARDS).

DATA SOURCES: We conducted a comprehensive search of MEDLINE, Embase, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials.

STUDY SELECTION: Studies were included if they reported effects of treatments on right ventricular function, whether or not the intent was to modify right ventricular function.

DATA EXTRACTION: Data extraction was performed independently and in duplicate by two authors. Data items included the study design, patient population, type of intervention, comparison group, and RV-specific outcomes.

DATA SYNTHESIS: Of 1,430 studies screened, 51 studies reporting on 1,526 patients were included. By frequency, the included studies examined the following interventions: ventilator settings (29.4%), inhaled medications (33.3%), extracorporeal life support (13.7%), intravenous or oral medications (13.7%), and prone positioning (9.8%). The majority of the studies were non-randomized experimental studies (53%), with the next most common being case reports (16%). Only 5.9% of studies were RCTs. In total, 27% of studies were conducted with the goal of modifying RV function.

CONCLUSIONS: Given the prevalence of RVD in ARDS and its association with mortality, the dearth of research on this topic is concerning. This review highlights the need for prospective trials aimed at treating RV dysfunction in ARDS.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ganeriwal S, Alves Dos Anjos G, Schleicher M, et al. Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review. Crit Care. 2023. PMID: 36907888. doi:10.1186/s13054-023-04395-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。